Litcius/Paper detail

Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: a phase 1 trial

Jeffrey S. Miller, Zachary Davis, Erika S. Helgeson, Cavan Reilly, Ann Thorkelson, Jodi Anderson, Noemia S. Lima, Siri Jorstad, Geoffrey T. Hart, John H Lee, Jeffrey T. Safrit, Hing C. Wong, Sarah Cooley, Lavina Gharu, Hyunsoo Chung, Patrick Soon‐Shiong, Curtis Dobrowolski, Courtney V. Fletcher, Jonathan Karn, Daniel C. Douek, Timothy W. Schacker

2022Nature Medicine107 citationsDOI

Topics & Concepts

TolerabilityMedicineRashAdverse effectCohortInternal medicineCD8DosingPharmacologyImmunologyImmune systemHIV Research and TreatmentImmune Cell Function and InteractionCytomegalovirus and herpesvirus research
Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: a phase 1 trial | Litcius